Comparing Belsomra vs Dayvigo
| Belsomra (suvorexant) | Dayvigo (lemborexant) |
|
|---|
| Belsomra (suvorexant) | Dayvigo (lemborexant) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Insomnia. Belsomra may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Insomnia. Dayvigo may also be used for purposes not listed in this medication guide. |
Related suggestions Insomnia
|
|||||||||||||||
| More about Belsomra (suvorexant) | More about Dayvigo (lemborexant) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Belsomra has an average rating of 3.9 out of 10 from a total of 542 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 62% reported a negative effect. |
Dayvigo has an average rating of 5.2 out of 10 from a total of 278 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 46% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Belsomra side effects |
View all Dayvigo side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Belsomra prices |
View all Dayvigo prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
12 hours |
19 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 499 drugs are known to interact with Belsomra:
|
A total of 468 drugs are known to interact with Dayvigo:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
August 13, 2014 |
December 20, 2019 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.